hemoglobin raffimer
Recombinant proteinexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started May 30, 2002 (NCT00038454)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hemoglobin beta chainSupplementation
HBB supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- Yes
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108963 ↗
Also known as
- hemoglobin raffimer
- hemoglobin raffimer
- hemoglobin-raffimer
- hemolink
- hemolink
- o-raffinose cross-linked human hemoglobin
- o-raffinose cross-linked oligomeric hemoglobin
- o-r-poly-hb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00038454 | Phase 2/Phase 3 (Phase 3) | May 30, 2002 | Hemosol |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hemosol | Academic/Hospital | 1 | 1 | 1 | 2002 |
1 organizations
Page 1 / 1